Literature DB >> 18977373

Free radical production from the interaction of 2-chloroethyl vesicants (mustard gas) with pyridine nucleotide-driven flavoprotein electron transport systems.

A A Brimfield1, A M Mancebo, R P Mason, J J Jiang, A G Siraki, M J Novak.   

Abstract

The biochemical sequelae to chloroethyl mustard exposure correspond very well to toxic processes initiated by free radicals. Additionally, mustard solutions contain spontaneously formed cyclic onium ions which produce carbon free radicals when reduced electrochemically. Therefore, we hypothesized that the onium ions of sulfur or nitrogen mustards might produce carbon free radicals upon being reduced enzymatically, and that these radicals might constitute a metabolic activation. We set out to document radical production using an in vitro metabolic system and electron paramagnetic resonance (EPR). Our system consisted of NADPH, one of several pyridine nucleotide-driven flavoprotein reductases, cytochrome c as a terminal electron acceptor, various sulfur or nitrogen mustards and the spin trap alpha-[4-pyridyl-1-oxide]-N-tert-butylnitrone in buffer. Reactions were started by adding the reductase to the other materials, vortexing and immediately transferring the mixture to a 10 mm EPR flat cell. Repeated scans on a Bruker ESP 300E EPR spectrometer produced a triplet of doublets with hyperfine splitting constants of a(N)=15.483 G and a(H)=2.512 G. The outcome supported our hypothesis that carbon-centered free radicals are produced when mustard-related onium ions are enzymatically reduced. The EPR results varied little with the chloroethyl compound used or with porcine or human cytochrome P450 reductase, the reductase domain of rat brain neuronal nitric oxide synthase or rat liver thioredoxin reductase. Our results offer new insight into the basis for mustard-induced vesication and the outcome of exposure to different mustards. The free radical model provides an explanation for similarities in the lesions arising from mustard exposure and energy-based lesions such as those from heat, ultraviolet and nuclear radiation as well as damage across tissue types such as skin, eyes or airway epithelium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977373      PMCID: PMC2703010          DOI: 10.1016/j.taap.2008.10.002

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  22 in total

1.  EFFECTS OF INSECTICIDE SYNERGISTS ON DURATION OF SLEEP INDUCED IN MICE BY BARBITURATES.

Authors:  B C FINE; J O MOLLOY
Journal:  Nature       Date:  1964-11-21       Impact factor: 49.962

2.  Effects in vivo of lymphoma ascites tumors and procarbazine, alone and in combination, upon hepatic drug- metabolizing enzymes of mice.

Authors:  D J Reed
Journal:  Biochem Pharmacol       Date:  1976-01-15       Impact factor: 5.858

3.  Preparation and assay of mammalian thioredoxin and thioredoxin reductase.

Authors:  E S Arnér; L Zhong; A Holmgren
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 4.  Electron spin resonance spin-trapping detection of superoxide generated by neuronal nitric oxide synthase.

Authors:  J Vásquez-Vivar; P Martásek; N Hogg; H Karoui; B S Masters; K A Pritchard; B Kalyanaraman
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

5.  Mechanism of the inhibitory action of isoniazid on microsomal drug metabolism.

Authors:  S F Muakkassah; W R Bidlack; W C Yang
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

6.  Effects of pesticides on drug and steroid metabolism.

Authors:  A H Conney; R M Welch; R Kuntzman; J J Burns
Journal:  Clin Pharmacol Ther       Date:  1967 Jan-Feb       Impact factor: 6.875

7.  The potentiation of barbiturate-induced narcosis by procarbazine.

Authors:  I P Lee; G W Lucier
Journal:  J Pharmacol Exp Ther       Date:  1976-03       Impact factor: 4.030

8.  Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin.

Authors:  C L Sabourin; J P Petrali; R P Casillas
Journal:  J Biochem Mol Toxicol       Date:  2000       Impact factor: 3.642

9.  Involvement of phenyl radicals in iodonium inhibition of flavoenzymes.

Authors:  V B O'Donnell; G C Smith; O T Jones
Journal:  Mol Pharmacol       Date:  1994-10       Impact factor: 4.436

10.  Inhibition of cytochrome P450 reductase by the diphenyliodonium cation. Kinetic analysis and covalent modifications.

Authors:  D G Tew
Journal:  Biochemistry       Date:  1993-09-28       Impact factor: 3.162

View more
  11 in total

1.  Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin.

Authors:  Anil K Jain; Neera Tewari-Singh; Mallikarjuna Gu; Swetha Inturi; Carl W White; Rajesh Agarwal
Journal:  Toxicol Lett       Date:  2011-06-21       Impact factor: 4.372

2.  Nitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators.

Authors:  Dileep Kumar; Neera Tewari-Singh; Chapla Agarwal; Anil K Jain; Swetha Inturi; Rama Kant; Carl W White; Rajesh Agarwal
Journal:  Toxicol Lett       Date:  2015-04-16       Impact factor: 4.372

3.  Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl ethyl sulfide is associated with increased production of reactive oxygen species.

Authors:  Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-02       Impact factor: 4.219

4.  Biological and molecular mechanisms of sulfur mustard analogue-induced toxicity in JB6 and HaCaT cells: possible role of ataxia telangiectasia-mutated/ataxia telangiectasia-Rad3-related cell cycle checkpoint pathway.

Authors:  Neera Tewari-Singh; Mallikarjuna Gu; Chapla Agarwal; Carl W White; Rajesh Agarwal
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

5.  Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide.

Authors:  Heidi C O'Neill; Carl W White; Livia A Veress; Tara B Hendry-Hofer; Joan E Loader; Elysia Min; Jie Huang; Raymond C Rancourt; Brian J Day
Journal:  Free Radic Biol Med       Date:  2010-02-04       Impact factor: 7.376

6.  Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects.

Authors:  Neera Tewari-Singh; Swetha Inturi; Anil K Jain; Chapla Agarwal; David J Orlicky; Carl W White; Rajesh Agarwal; Brian J Day
Journal:  Free Radic Biol Med       Date:  2014-05-09       Impact factor: 7.376

7.  Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.

Authors:  Neera Tewari-Singh; Anil K Jain; Swetha Inturi; David A Ammar; Chapla Agarwal; Puneet Tyagi; Uday B Kompella; Robert W Enzenauer; J Mark Petrash; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-24       Impact factor: 4.219

Review 8.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

9.  Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice.

Authors:  Arttatrana Pal; Neera Tewari-Singh; Mallikarjuna Gu; Chapla Agarwal; Jie Huang; Brian J Day; Carl W White; Rajesh Agarwal
Journal:  Free Radic Biol Med       Date:  2009-09-15       Impact factor: 7.376

10.  A role for mitochondrial oxidative stress in sulfur mustard analog 2-chloroethyl ethyl sulfide-induced lung cell injury and antioxidant protection.

Authors:  Neal S Gould; Carl W White; Brian J Day
Journal:  J Pharmacol Exp Ther       Date:  2008-12-08       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.